As of 2025-12-31, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (109.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -244.2%.
The range of the Relative Valuation is (99.25) - (122.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 17.8x | 15.6x |
| Forward P/E multiples | 14.4x - 18.0x | 16.2x |
| Fair Price | (99.25) - (122.68) | (109.58) |
| Upside | -230.6% - -261.4% | -244.2% |
| Date | P/E |